Effect of HCV, HIV and coinfection in kidney transplant recipients: Mate kidney analyses

American Journal of Transplantation

Volumn 14, Issue 9, 2014, Pages 2037-2047

  Xia, Y ^a,b   Friedmann, P ^b   Yaffe, H ^a,b   Phair, J ^b   Gupta, A ^a   Kayler, L K ^a,b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Health services and outcomes research; infection and infectious agents; kidney transplantation nephrology; viral: hepatitis C; viral: human immunodeficiency virus (HIV) acquired immunodeficiency syndrome (AIDS)

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; COMPLICATION; DONOR; HIV INFECTIONS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; TISSUE DONORS;

EID: 84906250057     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12847     Document Type: Article

References (43)

1. Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355-365.
2. Roth D, Gaynor JJ, Reddy KR, et al. Effect of kidney transplantation on outcomes among patients with hepatitis C. J Am Soc Nephrol 2011; 22: 1152-1160.
3. Scott DR, Wong JK, Spicer TS, et al. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation 2010; 90: 1165-1171.
4. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-263.
5. Ruhi C, Suleymanlar I, Kocak H, et al. The impact of hepatitis C virus infection on long-term outcome in renal transplant patients. Turk J Gastroenterol 2011; 22: 165-170.
6. Maluf DG, Fisher RA, King AL, et al. Hepatitis C virus infection and kidney transplantation: Predictors of patient and graft survival. Transplantation 2007; 83: 853-857.
7. Singh N, Neidlinger N, Djamali A, et al. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience. Clin Transplant 2012; 26: 684-693.
8. Bruchfeld A, Wilczek H, Elinder CG., Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation 2004; 78: 745-750.
9. Abbott KC, Lentine KL, Bucci JR, Agodoa LY, Peters TG, Schnitzler MA., The impact of transplantation with deceased donor Hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant 2004; 4: 2032-2037.
10. Morales JM, Campistol JM, Dominguez-Gil B, et al. Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients. Am J Transplant 2010; 10: 2453-2462.
11. Ingsathit A, Thakkinstian A, Kantachuvesiri S, Sumethkul V., Different impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation. Transplant Proc 2007; 39: 1424-1428.
12. Ridruejo E, Cusumano A, Diaz C, et al. Hepatitis C virus infection and outcome of renal transplantation. Transplant Proc 2007; 39: 3127-3130.
13. Gonzalez-Roncero F, Gentil MA, Valdivia MA, et al. Outcome of kidney transplant in chronic hepatitis C virus patients: Effect of pretransplantation interferon-alpha2b monotherapy. Transplant Proc 2003; 35: 1745-1747.
14. Morales JM, Dominguez-Gil B, Sanz-Guajardo D, Fernandez J, Escuin F., The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplant 2004; 19 (Suppl 3): iii72-iii76.
15. Forman JP, Tolkoff-Rubin N, Pascual M, Lin J., Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol 2004; 15: 3249-3255.
16. Lee WC, Shu KH, Cheng CH, Wu MJ, Chen CH, Lian JC., Long-term impact of hepatitis B, C virus infection on renal transplantation. Am J Nephrol 2001; 21: 300-306.
17. Hanafusa T, Ichikawa Y, Kishikawa H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471-476.
18. Darby SC, Ewart DW, Giangrande PL, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 1997; 350: 1425-1431.
19. Rockstroh JK, Spengler U, Sudhop T, et al. Immunosuppression may lead to progression of hepatitis C virus associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996; 91: 2563-2568.
20. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363: 2004-2014.
21. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G., Hepatitis C virus antibody status and survival after renal transplantation: Meta-analysis of observational studies. Am J Transplant 2005; 5: 1452-1461.
22. Mazuecos A, Fernandez A, Andres A, et al. HIV infection and renal transplantation. Nephrol Dial Transplant 2011; 26: 1401-1407.
23. Hua L, Andersen JW, Daar ES, Glesby MJ, Hollabaugh K, Tierney C., Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment. AIDS 2013; 27: 2725-2734.
24. Baid-Agrawal S, Pascual M, Moradpour D, Frei U, Tolkoff-Rubin N., Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol 2008; 18: 97-115.
25. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ., Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185.
26. Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667-670.
27. Kirk GD, Mehta SH, Astemborski J, et al. HIV, age, and the severity of hepatitis C virus-Related liver disease. Ann Intern Med 2013; 158: 658-666.
28. Keiser O, Spycher B, Rauch A, et al. Swiss HIV Cohort Study. Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: Latent class analysis. AIDS Behav 2012; 16: 245-255.
29. Kumar MS, Sierka DR, Damask AM, et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 2005; 67: 1622-1629.
30. Gasser O, Bihl F, Sanghavi S, et al. Treatment-dependent loss of polyfunctional CD8+ responses in HIV-infected kidney transplant recipients is associated with herpes virus reactivation. Am J Transplant 2009; 9: 794-803.
31. Qiu J, Terasaki PI, Waki K, Cai J, Gjertson DW., HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients. Transplantation 2006; 81: 1658-1661.
32. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL., Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004; 15: 1633-1639.
33. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30 (Suppl 1): S5-S14.
34. Carbone M, Mutimer D, Neuberger J., Hepatitis C virus and nonliver solid organ transplantation. Transplantation 2013; 95: 779-786.
35. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008; 73 (Suppl 109): S1-S99.
36. Schinazi R, Halfon P, Marcellin P, Asselah T., HCV direct-acting antiviral agents: The best interferon-free combinations. Liver Int 2014; 34: 69-78.
37. Thein HH, Yi Q, Dore GJ, Krahn MD., Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis. AIDS 2008; 22: 1979-1991.
38. Crusado JM, Casanovas-Taltavull T, Torras J, et al. Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance. Am J Transplant 2003; 3: 357-360.
39. Backus LI, Boothroyd DB, Phillips BR, Belperio P, Halloran J, Mole LA., A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol 2011; 9: 509-516.
40. Sulkowski MS., Current management of hepatitis C virus infection in patients with HIV coinfection. J Infect Dis 2013; 207: S26-S32.
41. Mehta SH, Genberg BL, Astemborski J, et al. Limited uptake of hepatitis C treatment among injection drug users. J Community Health 2008; 33: 126-133.
42. Mehta SH, Lucas GM, Mirel LB, et al. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 2006; 20: 2361-2369.
43. Thomas DL., The challenge of hepatitis C in the HIV-infected person. Annu Rev Med 2008; 59: 473-485.